| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 53 | 2024 | 3216 | 5.700 |
Why?
|
| Smoke | 19 | 2022 | 236 | 4.530 |
Why?
|
| Respiratory Mucosa | 24 | 2021 | 441 | 4.310 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 19 | 2023 | 1404 | 3.540 |
Why?
|
| Bronchitis, Chronic | 6 | 2023 | 82 | 3.230 |
Why?
|
| Smoking | 37 | 2024 | 9051 | 2.750 |
Why?
|
| Epithelial Cells | 30 | 2023 | 3664 | 2.680 |
Why?
|
| Pulmonary Emphysema | 10 | 2024 | 688 | 2.310 |
Why?
|
| Lung | 48 | 2024 | 9985 | 2.250 |
Why?
|
| Forced Expiratory Volume | 19 | 2024 | 1806 | 2.060 |
Why?
|
| Wood | 8 | 2022 | 92 | 1.760 |
Why?
|
| Mitochondrial Proteins | 8 | 2023 | 977 | 1.640 |
Why?
|
| Lipopolysaccharides | 18 | 2018 | 2204 | 1.600 |
Why?
|
| Emphysema | 3 | 2024 | 240 | 1.600 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2017 | 2895 | 1.590 |
Why?
|
| Hyperplasia | 15 | 2021 | 1154 | 1.520 |
Why?
|
| Pneumonia | 10 | 2023 | 2129 | 1.480 |
Why?
|
| Respiratory Syncytial Virus Infections | 4 | 2022 | 364 | 1.420 |
Why?
|
| Interleukin-13 | 5 | 2018 | 372 | 1.370 |
Why?
|
| Apoptosis Regulatory Proteins | 11 | 2023 | 1134 | 1.350 |
Why?
|
| Sputum | 6 | 2021 | 502 | 1.220 |
Why?
|
| Goblet Cells | 7 | 2016 | 299 | 1.180 |
Why?
|
| Allergens | 13 | 2021 | 1402 | 1.170 |
Why?
|
| Bronchi | 15 | 2021 | 848 | 1.150 |
Why?
|
| Bronchoalveolar Lavage Fluid | 20 | 2018 | 748 | 1.110 |
Why?
|
| Metaplasia | 16 | 2016 | 321 | 1.020 |
Why?
|
| Health Status | 5 | 2018 | 4071 | 1.000 |
Why?
|
| Influenza A virus | 3 | 2023 | 457 | 0.990 |
Why?
|
| Mucus | 8 | 2016 | 342 | 0.990 |
Why?
|
| Volatile Organic Compounds | 2 | 2022 | 84 | 0.960 |
Why?
|
| Uteroglobin | 5 | 2018 | 56 | 0.960 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2022 | 2912 | 0.950 |
Why?
|
| Apoptosis | 22 | 2023 | 9468 | 0.940 |
Why?
|
| Interferon-gamma | 10 | 2018 | 3156 | 0.940 |
Why?
|
| Orthomyxoviridae Infections | 3 | 2016 | 250 | 0.910 |
Why?
|
| bcl-2-Associated X Protein | 5 | 2008 | 282 | 0.900 |
Why?
|
| Hexosyltransferases | 1 | 2023 | 58 | 0.900 |
Why?
|
| Spirometry | 6 | 2023 | 923 | 0.900 |
Why?
|
| Mucin 5AC | 6 | 2018 | 97 | 0.820 |
Why?
|
| Autophagy | 4 | 2013 | 1322 | 0.820 |
Why?
|
| Casein Kinase II | 1 | 2021 | 122 | 0.750 |
Why?
|
| Rats, Inbred F344 | 15 | 2016 | 825 | 0.740 |
Why?
|
| Airway Remodeling | 3 | 2018 | 134 | 0.730 |
Why?
|
| Asthma | 15 | 2022 | 6172 | 0.730 |
Why?
|
| Vital Capacity | 7 | 2024 | 962 | 0.710 |
Why?
|
| Pyroglyphidae | 2 | 2018 | 88 | 0.700 |
Why?
|
| Animals | 102 | 2024 | 167768 | 0.690 |
Why?
|
| Mice, Inbred C57BL | 27 | 2024 | 22003 | 0.670 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2022 | 149 | 0.670 |
Why?
|
| Air Pollutants | 6 | 2022 | 2842 | 0.670 |
Why?
|
| Genes, bcl-2 | 4 | 2011 | 119 | 0.660 |
Why?
|
| Mucins | 5 | 2022 | 568 | 0.660 |
Why?
|
| Inflammation | 17 | 2023 | 10718 | 0.660 |
Why?
|
| Hypersensitivity | 3 | 2018 | 1155 | 0.640 |
Why?
|
| Mucous Membrane | 6 | 2011 | 656 | 0.630 |
Why?
|
| Trachea | 11 | 2017 | 1081 | 0.620 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2023 | 1312 | 0.620 |
Why?
|
| New Mexico | 7 | 2018 | 83 | 0.620 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2024 | 220 | 0.620 |
Why?
|
| DNA Methylation | 10 | 2020 | 4373 | 0.610 |
Why?
|
| Membrane Proteins | 15 | 2020 | 7843 | 0.600 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2018 | 66 | 0.600 |
Why?
|
| Interleukin-9 | 2 | 2008 | 61 | 0.590 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2017 | 71 | 0.580 |
Why?
|
| Gene Expression | 10 | 2022 | 7583 | 0.580 |
Why?
|
| Endoplasmic Reticulum | 2 | 2017 | 1130 | 0.570 |
Why?
|
| Respiratory Syncytial Viruses | 2 | 2016 | 167 | 0.550 |
Why?
|
| Matrix Metalloproteinase 9 | 4 | 2019 | 632 | 0.550 |
Why?
|
| Nasal Septum | 1 | 2018 | 130 | 0.550 |
Why?
|
| Mice | 50 | 2024 | 81101 | 0.540 |
Why?
|
| Poly I-C | 1 | 2016 | 112 | 0.530 |
Why?
|
| GATA4 Transcription Factor | 2 | 2014 | 124 | 0.530 |
Why?
|
| Ovalbumin | 9 | 2017 | 673 | 0.520 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2013 | 1972 | 0.510 |
Why?
|
| Caspase 3 | 3 | 2016 | 728 | 0.500 |
Why?
|
| Lysosomes | 1 | 2020 | 919 | 0.490 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2016 | 473 | 0.490 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2016 | 477 | 0.480 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2012 | 1927 | 0.470 |
Why?
|
| Cough | 1 | 2018 | 594 | 0.460 |
Why?
|
| Cell Death | 5 | 2016 | 1668 | 0.450 |
Why?
|
| Anoikis | 1 | 2013 | 48 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2014 | 311 | 0.450 |
Why?
|
| Pulmonary Alveoli | 6 | 2021 | 651 | 0.440 |
Why?
|
| Weight Gain | 2 | 2014 | 2346 | 0.440 |
Why?
|
| Cytokines | 13 | 2023 | 7338 | 0.430 |
Why?
|
| Immunity, Mucosal | 1 | 2016 | 481 | 0.430 |
Why?
|
| Tobacco Smoke Pollution | 5 | 2021 | 812 | 0.430 |
Why?
|
| Proteomics | 4 | 2024 | 3816 | 0.430 |
Why?
|
| Nasal Mucosa | 3 | 2004 | 412 | 0.420 |
Why?
|
| RNA | 3 | 2020 | 2716 | 0.420 |
Why?
|
| Sequence Analysis, RNA | 2 | 2020 | 2001 | 0.420 |
Why?
|
| Genes, p53 | 1 | 2014 | 712 | 0.400 |
Why?
|
| Interleukin-17 | 1 | 2018 | 908 | 0.400 |
Why?
|
| ADAM Proteins | 3 | 2020 | 238 | 0.400 |
Why?
|
| Humans | 118 | 2024 | 758406 | 0.390 |
Why?
|
| Gene Expression Regulation | 11 | 2019 | 11892 | 0.390 |
Why?
|
| Lung Neoplasms | 12 | 2020 | 13245 | 0.390 |
Why?
|
| Promoter Regions, Genetic | 8 | 2015 | 5779 | 0.390 |
Why?
|
| Particulate Matter | 2 | 2022 | 2556 | 0.390 |
Why?
|
| Rolipram | 1 | 2011 | 24 | 0.380 |
Why?
|
| Rats | 26 | 2018 | 23679 | 0.380 |
Why?
|
| Neutrophil Infiltration | 3 | 2016 | 390 | 0.370 |
Why?
|
| Homeostasis | 3 | 2020 | 3301 | 0.370 |
Why?
|
| Endothelial Cells | 1 | 2023 | 3533 | 0.360 |
Why?
|
| Neutrophils | 9 | 2019 | 3765 | 0.360 |
Why?
|
| Mice, Knockout | 16 | 2020 | 14354 | 0.360 |
Why?
|
| Male | 75 | 2024 | 358747 | 0.350 |
Why?
|
| Immunologic Memory | 1 | 2016 | 1353 | 0.340 |
Why?
|
| Macrophages, Alveolar | 7 | 2020 | 409 | 0.340 |
Why?
|
| Cell Division | 9 | 2021 | 4458 | 0.340 |
Why?
|
| Influenza, Human | 2 | 2023 | 1516 | 0.340 |
Why?
|
| Activities of Daily Living | 2 | 2016 | 2414 | 0.330 |
Why?
|
| Pneumonia, Viral | 2 | 2018 | 3196 | 0.330 |
Why?
|
| Disease Models, Animal | 17 | 2024 | 18119 | 0.320 |
Why?
|
| RNA, Messenger | 13 | 2021 | 12759 | 0.320 |
Why?
|
| Proteins | 10 | 2003 | 6026 | 0.320 |
Why?
|
| Viral Proteins | 1 | 2016 | 1801 | 0.320 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2008 | 88 | 0.310 |
Why?
|
| STAT1 Transcription Factor | 2 | 2007 | 333 | 0.310 |
Why?
|
| Interleukin-18 | 2 | 2007 | 250 | 0.300 |
Why?
|
| Mitochondria | 2 | 2020 | 3584 | 0.300 |
Why?
|
| Cell Nucleus | 3 | 2013 | 2907 | 0.300 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 1503 | 0.290 |
Why?
|
| Calcium | 4 | 2017 | 5721 | 0.290 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2006 | 4485 | 0.280 |
Why?
|
| Matrix Metalloproteinase 8 | 2 | 2019 | 56 | 0.280 |
Why?
|
| Cells, Cultured | 15 | 2020 | 18940 | 0.280 |
Why?
|
| Quality of Life | 3 | 2022 | 13285 | 0.280 |
Why?
|
| Respiratory Hypersensitivity | 2 | 2005 | 272 | 0.270 |
Why?
|
| Female | 60 | 2024 | 390323 | 0.270 |
Why?
|
| Middle Aged | 39 | 2024 | 219568 | 0.260 |
Why?
|
| Horse Diseases | 1 | 2006 | 54 | 0.260 |
Why?
|
| Respiratory Tract Diseases | 2 | 2024 | 747 | 0.260 |
Why?
|
| Lung Diseases | 2 | 2014 | 1910 | 0.260 |
Why?
|
| Health Status Disparities | 2 | 2017 | 1831 | 0.250 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2014 | 8506 | 0.250 |
Why?
|
| Inflammation Mediators | 5 | 2016 | 1878 | 0.250 |
Why?
|
| Carbon Monoxide | 3 | 2022 | 540 | 0.240 |
Why?
|
| Organ Culture Techniques | 3 | 2018 | 795 | 0.240 |
Why?
|
| Respiratory Mechanics | 1 | 2008 | 699 | 0.240 |
Why?
|
| Respiratory Function Tests | 7 | 2024 | 1680 | 0.240 |
Why?
|
| Bronchial Hyperreactivity | 4 | 2013 | 302 | 0.240 |
Why?
|
| Rats, Inbred BN | 5 | 2008 | 231 | 0.230 |
Why?
|
| Aged | 33 | 2024 | 168218 | 0.230 |
Why?
|
| Matrix Metalloproteinase 12 | 2 | 2016 | 44 | 0.220 |
Why?
|
| Cell Count | 5 | 2015 | 1835 | 0.220 |
Why?
|
| Inhalation Exposure | 6 | 2018 | 429 | 0.220 |
Why?
|
| Blotting, Western | 6 | 2011 | 5031 | 0.220 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 7 | 2003 | 15 | 0.220 |
Why?
|
| Peptides | 5 | 2017 | 4341 | 0.220 |
Why?
|
| Sugar Alcohols | 1 | 2022 | 17 | 0.210 |
Why?
|
| Retinoids | 3 | 2000 | 98 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2019 | 15773 | 0.210 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 1793 | 0.210 |
Why?
|
| Exocrine Glands | 1 | 2002 | 46 | 0.200 |
Why?
|
| Endothelium, Corneal | 1 | 2024 | 214 | 0.200 |
Why?
|
| Cross-Sectional Studies | 8 | 2024 | 25956 | 0.200 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2004 | 459 | 0.200 |
Why?
|
| Risk Factors | 18 | 2024 | 73809 | 0.200 |
Why?
|
| Protein Biosynthesis | 5 | 1996 | 2105 | 0.200 |
Why?
|
| Multivariate Analysis | 4 | 2018 | 12096 | 0.200 |
Why?
|
| Obesity | 2 | 2014 | 12870 | 0.190 |
Why?
|
| Environmental Exposure | 3 | 2018 | 4412 | 0.190 |
Why?
|
| Matrix Metalloproteinase 1 | 2 | 2019 | 142 | 0.190 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2015 | 411 | 0.190 |
Why?
|
| Respiratory System | 3 | 2021 | 557 | 0.190 |
Why?
|
| Genome-Wide Association Study | 9 | 2023 | 12604 | 0.180 |
Why?
|
| Airway Obstruction | 1 | 2006 | 661 | 0.180 |
Why?
|
| Antiporters | 1 | 2022 | 278 | 0.180 |
Why?
|
| Protective Agents | 1 | 2021 | 150 | 0.180 |
Why?
|
| Mortality | 2 | 2024 | 2886 | 0.180 |
Why?
|
| Cystic Fibrosis | 2 | 2012 | 1274 | 0.180 |
Why?
|
| Adult | 29 | 2024 | 219935 | 0.180 |
Why?
|
| Carbohydrates | 1 | 2022 | 388 | 0.180 |
Why?
|
| Air Pollution | 2 | 2005 | 2314 | 0.170 |
Why?
|
| Chemokines | 3 | 2015 | 961 | 0.170 |
Why?
|
| Disease Progression | 6 | 2021 | 13468 | 0.170 |
Why?
|
| Time Factors | 8 | 2016 | 39872 | 0.170 |
Why?
|
| Peptide Biosynthesis | 3 | 1993 | 52 | 0.170 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 10171 | 0.160 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2019 | 151 | 0.160 |
Why?
|
| Logistic Models | 5 | 2018 | 13276 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2020 | 419 | 0.150 |
Why?
|
| Sphingolipids | 1 | 2020 | 173 | 0.150 |
Why?
|
| Genes, Tumor Suppressor | 3 | 1997 | 1055 | 0.150 |
Why?
|
| Pancreatic Elastase | 1 | 2018 | 128 | 0.150 |
Why?
|
| GTPase-Activating Proteins | 1 | 2021 | 474 | 0.150 |
Why?
|
| Intermediate Filament Proteins | 1 | 1999 | 262 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2019 | 17768 | 0.150 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2018 | 97 | 0.150 |
Why?
|
| Cricetinae | 5 | 2003 | 2426 | 0.150 |
Why?
|
| Epithelium | 7 | 1998 | 1605 | 0.150 |
Why?
|
| Gases | 1 | 2018 | 203 | 0.140 |
Why?
|
| Enzyme Activation | 2 | 2016 | 3593 | 0.140 |
Why?
|
| Swine | 7 | 1996 | 5892 | 0.140 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2016 | 91 | 0.140 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 15785 | 0.140 |
Why?
|
| Species Specificity | 2 | 2015 | 2417 | 0.140 |
Why?
|
| Pulmonary Fibrosis | 2 | 2019 | 506 | 0.140 |
Why?
|
| Mice, Inbred C3H | 2 | 2015 | 915 | 0.140 |
Why?
|
| NF-kappa B | 4 | 2023 | 2472 | 0.140 |
Why?
|
| Virus Replication | 3 | 2023 | 2430 | 0.130 |
Why?
|
| Endophenotypes | 1 | 2018 | 255 | 0.130 |
Why?
|
| CHO Cells | 4 | 2003 | 1389 | 0.130 |
Why?
|
| Cohort Studies | 10 | 2024 | 41256 | 0.130 |
Why?
|
| Lung Injury | 1 | 2021 | 424 | 0.130 |
Why?
|
| Fever | 5 | 2002 | 1617 | 0.130 |
Why?
|
| Gene Silencing | 2 | 2013 | 1507 | 0.130 |
Why?
|
| Markov Chains | 2 | 2016 | 965 | 0.130 |
Why?
|
| Antigens, CD | 2 | 2018 | 3997 | 0.130 |
Why?
|
| Ubiquitination | 2 | 2018 | 1006 | 0.130 |
Why?
|
| Multigene Family | 1 | 1999 | 1076 | 0.130 |
Why?
|
| Nuclear Proteins | 2 | 2023 | 5786 | 0.130 |
Why?
|
| Aerosols | 3 | 2011 | 631 | 0.120 |
Why?
|
| Linear Models | 2 | 2016 | 5862 | 0.120 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 601 | 0.120 |
Why?
|
| Mice, Nude | 2 | 2016 | 3602 | 0.120 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2015 | 105 | 0.120 |
Why?
|
| Comorbidity | 3 | 2018 | 10495 | 0.120 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2014 | 37 | 0.120 |
Why?
|
| Endothelium | 1 | 2017 | 764 | 0.120 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 3754 | 0.120 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2014 | 54 | 0.120 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2017 | 540 | 0.120 |
Why?
|
| Vitamin A | 3 | 1993 | 613 | 0.120 |
Why?
|
| Molecular Sequence Data | 10 | 2004 | 17617 | 0.120 |
Why?
|
| Chick Embryo | 1 | 2016 | 981 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2011 | 10748 | 0.110 |
Why?
|
| Case-Control Studies | 8 | 2020 | 22029 | 0.110 |
Why?
|
| Dyspnea | 1 | 2022 | 1344 | 0.110 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 560 | 0.110 |
Why?
|
| Base Sequence | 8 | 2006 | 12436 | 0.110 |
Why?
|
| Metformin | 1 | 2021 | 907 | 0.110 |
Why?
|
| Polyvinyls | 1 | 1994 | 154 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2013 | 772 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2001 | 1866 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 362 | 0.110 |
Why?
|
| Mice, Mutant Strains | 2 | 2007 | 1751 | 0.110 |
Why?
|
| Butyric Acid | 1 | 2013 | 51 | 0.110 |
Why?
|
| Phenotype | 8 | 2019 | 16534 | 0.110 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2016 | 663 | 0.110 |
Why?
|
| Ribonucleoproteins | 1 | 2016 | 372 | 0.110 |
Why?
|
| Th2 Cells | 3 | 2008 | 1047 | 0.110 |
Why?
|
| Interleukin-6 | 3 | 2002 | 3208 | 0.110 |
Why?
|
| Nicotine | 3 | 2016 | 677 | 0.110 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2013 | 146 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 577 | 0.110 |
Why?
|
| Bezafibrate | 2 | 2003 | 14 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2015 | 1074 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 1999 | 2753 | 0.110 |
Why?
|
| Health Status Indicators | 2 | 2018 | 970 | 0.100 |
Why?
|
| Membranes, Artificial | 1 | 1994 | 366 | 0.100 |
Why?
|
| Matrix Metalloproteinases | 1 | 2015 | 392 | 0.100 |
Why?
|
| Sarin | 2 | 2002 | 4 | 0.100 |
Why?
|
| Histone Deacetylase 1 | 1 | 2013 | 134 | 0.100 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 597 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3774 | 0.100 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 372 | 0.100 |
Why?
|
| Dogs | 2 | 2016 | 3840 | 0.100 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 6313 | 0.100 |
Why?
|
| Chemical Warfare Agents | 2 | 2002 | 19 | 0.100 |
Why?
|
| Transcription Factors | 3 | 2022 | 12094 | 0.100 |
Why?
|
| Lipoxins | 1 | 2015 | 418 | 0.100 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 726 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4567 | 0.100 |
Why?
|
| Dinoprostone | 1 | 2015 | 598 | 0.100 |
Why?
|
| Aniline Compounds | 1 | 2017 | 1068 | 0.100 |
Why?
|
| Proline | 1 | 1993 | 456 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 611 | 0.100 |
Why?
|
| Amino Acid Sequence | 9 | 1999 | 13447 | 0.100 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2015 | 316 | 0.100 |
Why?
|
| Government Regulation | 1 | 2016 | 524 | 0.100 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2011 | 59 | 0.100 |
Why?
|
| Signal Transduction | 7 | 2020 | 23342 | 0.100 |
Why?
|
| Macaca fascicularis | 3 | 2021 | 900 | 0.100 |
Why?
|
| Cytoplasm | 1 | 2016 | 1514 | 0.100 |
Why?
|
| Odds Ratio | 3 | 2022 | 9650 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2020 | 4549 | 0.090 |
Why?
|
| Carcinogens | 3 | 2003 | 451 | 0.090 |
Why?
|
| Interleukin-8 | 1 | 2014 | 696 | 0.090 |
Why?
|
| Genetic Loci | 2 | 2019 | 2612 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2024 | 14490 | 0.090 |
Why?
|
| Proline-Rich Protein Domains | 4 | 1995 | 9 | 0.090 |
Why?
|
| Haplotypes | 4 | 2015 | 2764 | 0.090 |
Why?
|
| Alcian Blue | 2 | 2007 | 13 | 0.090 |
Why?
|
| Periodic Acid-Schiff Reaction | 2 | 2007 | 16 | 0.090 |
Why?
|
| Lymphocytes | 2 | 2016 | 2610 | 0.090 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 16886 | 0.090 |
Why?
|
| Air Pollution, Indoor | 1 | 2018 | 893 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3425 | 0.090 |
Why?
|
| Indians, North American | 1 | 2014 | 350 | 0.090 |
Why?
|
| Acetylation | 1 | 2013 | 1060 | 0.090 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 481 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2017 | 2697 | 0.090 |
Why?
|
| Metabolomics | 1 | 2019 | 1629 | 0.090 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2009 | 56 | 0.090 |
Why?
|
| Genotype | 5 | 2015 | 12945 | 0.090 |
Why?
|
| Genes, p16 | 1 | 2010 | 159 | 0.090 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2009 | 90 | 0.090 |
Why?
|
| Cell Differentiation | 6 | 2011 | 11471 | 0.090 |
Why?
|
| Horses | 2 | 2011 | 298 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2019 | 3680 | 0.080 |
Why?
|
| Sex Characteristics | 2 | 2015 | 2621 | 0.080 |
Why?
|
| Cilia | 1 | 2013 | 493 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1611 | 0.080 |
Why?
|
| Nutritional Status | 1 | 2017 | 1607 | 0.080 |
Why?
|
| Lactococcus lactis | 1 | 1989 | 29 | 0.080 |
Why?
|
| Gene Deletion | 1 | 1997 | 2666 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 718 | 0.080 |
Why?
|
| Cathepsin D | 1 | 2008 | 59 | 0.080 |
Why?
|
| RNA, Catalytic | 1 | 2008 | 53 | 0.080 |
Why?
|
| Cathepsin B | 1 | 2008 | 80 | 0.080 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2379 | 0.080 |
Why?
|
| Annexin A5 | 1 | 2008 | 103 | 0.080 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2010 | 356 | 0.080 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2008 | 46 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 1743 | 0.080 |
Why?
|
| Transcription, Genetic | 4 | 2003 | 7590 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2019 | 2868 | 0.080 |
Why?
|
| Maternal Exposure | 1 | 2015 | 1045 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 3 | 2004 | 6068 | 0.080 |
Why?
|
| Cell Cycle | 1 | 1996 | 2930 | 0.080 |
Why?
|
| Stem Cells | 1 | 2021 | 3521 | 0.080 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2014 | 500 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 532 | 0.080 |
Why?
|
| Cell Survival | 3 | 2019 | 5781 | 0.080 |
Why?
|
| Genetic Markers | 2 | 2011 | 2608 | 0.080 |
Why?
|
| Hematoxylin | 1 | 2007 | 60 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2014 | 9267 | 0.070 |
Why?
|
| Protein Transport | 2 | 2019 | 1963 | 0.070 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2007 | 69 | 0.070 |
Why?
|
| Genetics, Population | 1 | 2013 | 929 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1444 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2017 | 1973 | 0.070 |
Why?
|
| Hemagglutinins | 1 | 2007 | 113 | 0.070 |
Why?
|
| Muscle Cells | 1 | 2008 | 194 | 0.070 |
Why?
|
| Prevalence | 2 | 2022 | 15651 | 0.070 |
Why?
|
| DNA Damage | 2 | 2014 | 2439 | 0.070 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 192 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 4406 | 0.070 |
Why?
|
| Interleukin-13 Receptor alpha2 Subunit | 1 | 2006 | 7 | 0.070 |
Why?
|
| Carrier Proteins | 2 | 1997 | 4938 | 0.070 |
Why?
|
| Cytochromes c | 1 | 2007 | 173 | 0.070 |
Why?
|
| Ozone | 2 | 2002 | 477 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1997 | 2800 | 0.070 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 1999 | 818 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 9518 | 0.070 |
Why?
|
| Southwestern United States | 1 | 2006 | 39 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 996 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 1723 | 0.060 |
Why?
|
| Eosinophils | 3 | 2013 | 946 | 0.060 |
Why?
|
| Receptor, erbB-2 | 1 | 1996 | 2553 | 0.060 |
Why?
|
| DNA Primers | 2 | 2003 | 2816 | 0.060 |
Why?
|
| Cyclin D1 | 2 | 1998 | 451 | 0.060 |
Why?
|
| Bacteriophages | 1 | 1989 | 372 | 0.060 |
Why?
|
| Age Distribution | 1 | 2011 | 2882 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2016 | 8297 | 0.060 |
Why?
|
| Overweight | 1 | 2016 | 2411 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2016 | 698 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 1997 | 3442 | 0.060 |
Why?
|
| Myeloid Cells | 1 | 2010 | 820 | 0.060 |
Why?
|
| Cell Line | 3 | 2016 | 15591 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2007 | 560 | 0.060 |
Why?
|
| Cyclic AMP | 2 | 2003 | 1455 | 0.060 |
Why?
|
| Pedigree | 1 | 2013 | 4578 | 0.060 |
Why?
|
| Blotting, Northern | 3 | 1996 | 1543 | 0.060 |
Why?
|
| Models, Biological | 2 | 2013 | 9460 | 0.060 |
Why?
|
| Haplorhini | 2 | 1996 | 529 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2796 | 0.060 |
Why?
|
| Up-Regulation | 3 | 2016 | 4113 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2006 | 345 | 0.060 |
Why?
|
| Autopsy | 1 | 2008 | 1003 | 0.060 |
Why?
|
| Public Health | 1 | 2017 | 2658 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 15225 | 0.060 |
Why?
|
| Escherichia coli | 1 | 1996 | 4215 | 0.060 |
Why?
|
| Macrophages | 2 | 2016 | 5737 | 0.060 |
Why?
|
| Oxidative Stress | 4 | 2017 | 3099 | 0.060 |
Why?
|
| Beryllium | 1 | 2003 | 14 | 0.060 |
Why?
|
| Molecular Epidemiology | 1 | 2006 | 469 | 0.060 |
Why?
|
| Kinetics | 3 | 2002 | 6371 | 0.050 |
Why?
|
| Antioxidants | 1 | 2011 | 1662 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2007 | 1084 | 0.050 |
Why?
|
| Nitrosamines | 1 | 2003 | 87 | 0.050 |
Why?
|
| Ploidies | 1 | 2003 | 275 | 0.050 |
Why?
|
| Costa Rica | 2 | 2014 | 177 | 0.050 |
Why?
|
| Nucleoproteins | 1 | 2023 | 113 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2007 | 1414 | 0.050 |
Why?
|
| Alpha-Globulins | 1 | 2002 | 26 | 0.050 |
Why?
|
| Body Weight | 3 | 2002 | 4603 | 0.050 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2024 | 100 | 0.050 |
Why?
|
| Hypoxanthines | 1 | 2021 | 35 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2002 | 530 | 0.050 |
Why?
|
| Gene Frequency | 3 | 2015 | 3612 | 0.050 |
Why?
|
| Hospitalization | 1 | 2022 | 10652 | 0.050 |
Why?
|
| United States | 5 | 2023 | 72136 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 2057 | 0.050 |
Why?
|
| Rabbits | 3 | 1998 | 4772 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2004 | 583 | 0.050 |
Why?
|
| Nitrogen Oxides | 1 | 2002 | 128 | 0.050 |
Why?
|
| Body Temperature | 2 | 2002 | 777 | 0.050 |
Why?
|
| Kidney | 1 | 2017 | 7016 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2005 | 1130 | 0.050 |
Why?
|
| Diet | 2 | 2017 | 8005 | 0.050 |
Why?
|
| Acute Disease | 1 | 2012 | 7225 | 0.050 |
Why?
|
| Papio papio | 1 | 2021 | 3 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2012 | 9404 | 0.050 |
Why?
|
| Benzo(a)pyrene | 1 | 2001 | 27 | 0.050 |
Why?
|
| Leukocyte Count | 2 | 2004 | 1593 | 0.050 |
Why?
|
| Cytosol | 2 | 2013 | 886 | 0.050 |
Why?
|
| Pigmentation | 1 | 2002 | 144 | 0.050 |
Why?
|
| Hydrocarbons | 1 | 2002 | 105 | 0.050 |
Why?
|
| Pituitary-Adrenal System | 2 | 2001 | 551 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2006 | 1031 | 0.050 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2021 | 173 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2016 | 10416 | 0.050 |
Why?
|
| Persian Gulf Syndrome | 1 | 2001 | 47 | 0.050 |
Why?
|
| Dissection | 1 | 2002 | 297 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2004 | 942 | 0.050 |
Why?
|
| In Situ Hybridization | 2 | 1996 | 1900 | 0.050 |
Why?
|
| Molecular Weight | 2 | 1995 | 2185 | 0.050 |
Why?
|
| Bronchitis | 1 | 2001 | 196 | 0.050 |
Why?
|
| Age Factors | 2 | 2021 | 18358 | 0.050 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2002 | 238 | 0.050 |
Why?
|
| Eosinophilia | 2 | 2002 | 559 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 1759 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2010 | 6354 | 0.050 |
Why?
|
| Receptors, Cholinergic | 1 | 2001 | 241 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2001 | 699 | 0.040 |
Why?
|
| Incidence | 1 | 2018 | 21272 | 0.040 |
Why?
|
| bcl-X Protein | 1 | 2002 | 411 | 0.040 |
Why?
|
| P-Selectin | 1 | 2002 | 597 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 2557 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2017 | 12876 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2001 | 427 | 0.040 |
Why?
|
| Caspases | 1 | 2023 | 876 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2013 | 2470 | 0.040 |
Why?
|
| Capsaicin | 1 | 2001 | 231 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 11070 | 0.040 |
Why?
|
| Infant | 1 | 2022 | 36055 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2000 | 224 | 0.040 |
Why?
|
| Protein Binding | 1 | 2012 | 9311 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 1897 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 2443 | 0.040 |
Why?
|
| Endotoxins | 1 | 2002 | 521 | 0.040 |
Why?
|
| Probability | 1 | 2004 | 2467 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2004 | 1038 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2010 | 2723 | 0.040 |
Why?
|
| Interleukin-1 | 2 | 2002 | 1249 | 0.040 |
Why?
|
| Epidemics | 1 | 2024 | 512 | 0.040 |
Why?
|
| Software | 1 | 2013 | 4415 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2021 | 2672 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 15399 | 0.040 |
Why?
|
| Hypolipidemic Agents | 1 | 2003 | 609 | 0.040 |
Why?
|
| Sodium Chloride | 1 | 2000 | 588 | 0.040 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 1999 | 95 | 0.040 |
Why?
|
| Lymphocyte Depletion | 1 | 2020 | 602 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 1999 | 365 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 1136 | 0.040 |
Why?
|
| Neurons, Afferent | 1 | 2001 | 498 | 0.040 |
Why?
|
| Household Products | 1 | 2018 | 27 | 0.040 |
Why?
|
| Immune System | 2 | 2001 | 796 | 0.040 |
Why?
|
| Digestive System | 1 | 1999 | 244 | 0.040 |
Why?
|
| Cecum | 1 | 1998 | 232 | 0.040 |
Why?
|
| Particle Size | 1 | 2002 | 1641 | 0.040 |
Why?
|
| Reference Values | 1 | 2004 | 4919 | 0.040 |
Why?
|
| Carbon | 1 | 2001 | 667 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39059 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2001 | 800 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 4 | 2013 | 6209 | 0.040 |
Why?
|
| Mice, Inbred A | 1 | 1997 | 246 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 1997 | 70 | 0.040 |
Why?
|
| Larynx | 1 | 2002 | 492 | 0.040 |
Why?
|
| Transfection | 2 | 2003 | 5779 | 0.030 |
Why?
|
| Nociceptors | 1 | 2001 | 457 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6127 | 0.030 |
Why?
|
| Down-Regulation | 3 | 2015 | 2904 | 0.030 |
Why?
|
| DNA | 3 | 2003 | 7199 | 0.030 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2016 | 83 | 0.030 |
Why?
|
| Plants, Toxic | 1 | 1996 | 74 | 0.030 |
Why?
|
| Sex Factors | 1 | 2010 | 10504 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2021 | 1020 | 0.030 |
Why?
|
| Animal Experimentation | 1 | 2016 | 46 | 0.030 |
Why?
|
| Vehicle Emissions | 1 | 2001 | 655 | 0.030 |
Why?
|
| Mucociliary Clearance | 1 | 2016 | 80 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2002 | 4342 | 0.030 |
Why?
|
| Mecamylamine | 1 | 2015 | 27 | 0.030 |
Why?
|
| Nuclear Matrix | 1 | 1995 | 30 | 0.030 |
Why?
|
| Epidermis | 1 | 1999 | 528 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 2016 | 574 | 0.030 |
Why?
|
| Cooking | 1 | 2018 | 311 | 0.030 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2015 | 45 | 0.030 |
Why?
|
| Spleen | 1 | 2001 | 2296 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2019 | 541 | 0.030 |
Why?
|
| G1 Phase | 1 | 1996 | 403 | 0.030 |
Why?
|
| Phospholipases A2, Secretory | 1 | 2015 | 30 | 0.030 |
Why?
|
| DNA Probes | 1 | 1996 | 543 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 4284 | 0.030 |
Why?
|
| Eating | 1 | 2001 | 1536 | 0.030 |
Why?
|
| Heterozygote | 1 | 2001 | 2797 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20500 | 0.030 |
Why?
|
| Cyclins | 1 | 1997 | 593 | 0.030 |
Why?
|
| Fibrinolysin | 1 | 2014 | 131 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2001 | 1398 | 0.030 |
Why?
|
| Methylation | 1 | 1997 | 1080 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2014 | 95 | 0.030 |
Why?
|
| Keratins | 1 | 2015 | 497 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 2201 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2019 | 54137 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2001 | 1197 | 0.030 |
Why?
|
| Azacitidine | 2 | 2011 | 334 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 58683 | 0.030 |
Why?
|
| Equipment Design | 1 | 2002 | 3507 | 0.030 |
Why?
|
| Bucladesine | 1 | 1993 | 118 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2015 | 419 | 0.030 |
Why?
|
| Mesocricetus | 1 | 1993 | 252 | 0.030 |
Why?
|
| Recurrence | 1 | 2006 | 8426 | 0.030 |
Why?
|
| Phenylbutyrates | 1 | 2013 | 72 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1996 | 1647 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 1996 | 1705 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 29557 | 0.030 |
Why?
|
| Hypothalamus | 1 | 1998 | 998 | 0.030 |
Why?
|
| Retinoblastoma Protein | 1 | 1997 | 670 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2022 | 4257 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9160 | 0.030 |
Why?
|
| Child | 5 | 2024 | 79818 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1993 | 814 | 0.030 |
Why?
|
| Aldehydes | 1 | 2013 | 170 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 1997 | 719 | 0.030 |
Why?
|
| Alleles | 2 | 2017 | 6895 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1993 | 1055 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2002 | 2860 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 246 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2001 | 2144 | 0.020 |
Why?
|
| DNA Ligases | 1 | 2011 | 82 | 0.020 |
Why?
|
| Aging | 2 | 2022 | 8650 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 940 | 0.020 |
Why?
|
| Oncogenes | 1 | 1997 | 1220 | 0.020 |
Why?
|
| Gelatinases | 1 | 2011 | 88 | 0.020 |
Why?
|
| Motor Activity | 1 | 2001 | 2685 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2011 | 148 | 0.020 |
Why?
|
| Enzyme Precursors | 1 | 2011 | 174 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 2057 | 0.020 |
Why?
|
| Mesothelioma | 1 | 1997 | 807 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 2129 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 374 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 1997 | 4624 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1993 | 414 | 0.020 |
Why?
|
| Drug Design | 1 | 2016 | 1049 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2003 | 2496 | 0.020 |
Why?
|
| Cell Movement | 1 | 2003 | 5201 | 0.020 |
Why?
|
| Europe | 1 | 2017 | 3420 | 0.020 |
Why?
|
| Cell-Free System | 1 | 1990 | 340 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1992 | 635 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11709 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 358 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 940 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 14641 | 0.020 |
Why?
|
| Nasal Obstruction | 1 | 2011 | 159 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 461 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2024 | 42062 | 0.020 |
Why?
|
| Culture Media | 1 | 2011 | 899 | 0.020 |
Why?
|
| Biomedical Research | 2 | 2017 | 3418 | 0.020 |
Why?
|
| Ambrosia | 1 | 2008 | 6 | 0.020 |
Why?
|
| Immunoglobulin E | 2 | 2008 | 1484 | 0.020 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2008 | 33 | 0.020 |
Why?
|
| Antibodies | 1 | 1996 | 2420 | 0.020 |
Why?
|
| Leukotriene C4 | 1 | 2008 | 79 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 20055 | 0.020 |
Why?
|
| Young Adult | 3 | 2024 | 58808 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2008 | 189 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 1996 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2016 | 1659 | 0.020 |
Why?
|
| Clone Cells | 1 | 2011 | 1660 | 0.020 |
Why?
|
| Adolescent | 3 | 2024 | 87892 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2008 | 13591 | 0.020 |
Why?
|
| Immunoglobulin G | 3 | 2008 | 4540 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2001 | 3975 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1996 | 5864 | 0.020 |
Why?
|
| Leukocytes | 1 | 2014 | 2025 | 0.020 |
Why?
|
| Fruit | 1 | 2011 | 1160 | 0.020 |
Why?
|
| Vegetables | 1 | 2011 | 1195 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10112 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2001 | 2262 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 2047 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12721 | 0.020 |
Why?
|
| Benzamides | 1 | 2011 | 1368 | 0.020 |
Why?
|
| Skin | 1 | 1999 | 4464 | 0.020 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2004 | 57 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 9574 | 0.010 |
Why?
|
| International Cooperation | 1 | 2011 | 1430 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 3432 | 0.010 |
Why?
|
| Sepsis | 1 | 1998 | 2587 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 2004 | 242 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1996 | 5098 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2017 | 8553 | 0.010 |
Why?
|
| Bronchiolitis, Viral | 1 | 2004 | 82 | 0.010 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2003 | 48 | 0.010 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2003 | 41 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 2004 | 310 | 0.010 |
Why?
|
| Mutation | 2 | 2019 | 29915 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2717 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 3480 | 0.010 |
Why?
|
| Turpentine | 1 | 2002 | 10 | 0.010 |
Why?
|
| Risk | 1 | 2015 | 9599 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2004 | 728 | 0.010 |
Why?
|
| Acetylcholinesterase | 1 | 2002 | 156 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 3574 | 0.010 |
Why?
|
| Macaca mulatta | 3 | 1993 | 2316 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 2002 | 157 | 0.010 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2001 | 77 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2001 | 108 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 2001 | 216 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 2001 | 220 | 0.010 |
Why?
|
| Solvents | 1 | 2002 | 292 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2001 | 219 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 2001 | 149 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2001 | 361 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6493 | 0.010 |
Why?
|
| Computational Biology | 1 | 2013 | 3502 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2001 | 700 | 0.010 |
Why?
|
| Autoradiography | 1 | 2001 | 730 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2001 | 412 | 0.010 |
Why?
|
| Concanavalin A | 1 | 2000 | 190 | 0.010 |
Why?
|
| Biological Availability | 1 | 2001 | 390 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2021 | 64378 | 0.010 |
Why?
|
| Airway Resistance | 1 | 2001 | 400 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 2001 | 223 | 0.010 |
Why?
|
| Denervation | 1 | 2001 | 263 | 0.010 |
Why?
|
| Afferent Pathways | 1 | 2001 | 298 | 0.010 |
Why?
|
| Genome, Human | 1 | 2013 | 4416 | 0.010 |
Why?
|
| Naphthalenes | 1 | 2000 | 198 | 0.010 |
Why?
|
| Lymphocyte Activation | 2 | 2001 | 5490 | 0.010 |
Why?
|
| Exploratory Behavior | 1 | 2001 | 273 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 2836 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 2001 | 471 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1999 | 5797 | 0.010 |
Why?
|
| Exons | 2 | 1997 | 2387 | 0.010 |
Why?
|
| Corticosterone | 1 | 2000 | 304 | 0.010 |
Why?
|
| Pyridines | 1 | 2011 | 2859 | 0.010 |
Why?
|
| Pregnancy | 2 | 2015 | 29742 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2001 | 8143 | 0.010 |
Why?
|
| Peritonitis | 1 | 2001 | 369 | 0.010 |
Why?
|
| Peroxidase | 1 | 2001 | 605 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 1998 | 225 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2000 | 1154 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2006 | 2772 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 2000 | 348 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2018 | 80168 | 0.010 |
Why?
|
| Neuroimmunomodulation | 1 | 2000 | 177 | 0.010 |
Why?
|
| Microinjections | 1 | 1998 | 321 | 0.010 |
Why?
|
| Ligation | 1 | 1998 | 448 | 0.010 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 1997 | 84 | 0.010 |
Why?
|
| Punctures | 1 | 1998 | 365 | 0.010 |
Why?
|
| Foot | 1 | 2001 | 573 | 0.010 |
Why?
|
| Immunization | 1 | 2001 | 1227 | 0.010 |
Why?
|
| Cell Physiological Phenomena | 1 | 1997 | 150 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1998 | 6520 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2001 | 1871 | 0.010 |
Why?
|
| Atrophy | 1 | 2001 | 1627 | 0.010 |
Why?
|
| Viral Load | 1 | 2004 | 3321 | 0.010 |
Why?
|
| Models, Animal | 1 | 2001 | 2112 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 2001 | 1166 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1993 | 221 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2008 | 5249 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1993 | 852 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1997 | 1492 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1993 | 285 | 0.010 |
Why?
|
| CpG Islands | 1 | 1997 | 1221 | 0.010 |
Why?
|
| Algorithms | 1 | 2013 | 13961 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1992 | 777 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 4169 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 3709 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2000 | 2416 | 0.010 |
Why?
|
| Introns | 1 | 1993 | 978 | 0.010 |
Why?
|
| Karyotyping | 1 | 1992 | 1171 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1998 | 1401 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1993 | 1199 | 0.000 |
Why?
|
| HeLa Cells | 1 | 1993 | 3096 | 0.000 |
Why?
|
| Liver | 1 | 2002 | 7502 | 0.000 |
Why?
|
| Head and Neck Neoplasms | 1 | 2000 | 2882 | 0.000 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 4711 | 0.000 |
Why?
|
| Brain | 2 | 2002 | 26947 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2000 | 4023 | 0.000 |
Why?
|
| Binding Sites | 1 | 1993 | 6036 | 0.000 |
Why?
|